 International IP and the Public Interest | Bayer fails to suspend sales of generic Nexavar in India Pharma Times Bayer fails to suspend sales of generic Nexavar in India. German drugmaker Bayer has failed in the first stage of its bid to stop Indian group Natco from selling a rock-bottom-priced version of its liver and kidney cancer drug Nexavar in India. Bayer ... India Appeals Body Rejects Bayer's Plea to Suspend Sales of Generic Nexavar Patent rights, a fillip for Natco Pharma Bayer's plea for stay on Nexavar generic in India dismissed |
